Nebenwirkungen · Dzuveo
Dzuveo 30 micrograms sublingual tablet · Abschnitt 4.8 · PDF-Seite 6–7
HOS-137944 · Präparat HOS-098113
6 MedDRA system organ Very Common Uncommon Not known class common Psychiatric disorders Insomnia Agitation Anxiety Apathy Confusional state Conversion disorder Disorientation Euphoric mood Hallucination Mental status changes Nervousness Nervous system disorders Headache Tremor Convulsions Dizziness Ataxia Coma Somnolence Dystonia Sedation Hyperreflexia Burning sensation Presyncope Paraesthesia Hypoaesthesia Lethargy Memory impairment Migraine Tension headache Eye disorders Eye pain Miosis Visual disturbance Cardiac disorders Tachycardia Bradycardia Sinus tachycardia Angina pectoris Atrial fibrillation Ventricular extrasystoles Vascular disorders Hypotension Orthostatic hypertension Hypertension Flushing Diastolic hypotension Orthostatic hypotension Respiratory, thoracic and Hypoxia Bradypnoea Respiratory arrest mediastinal disorders Pharyngolaryngeal Epistaxis pain Hiccups Respiratory Apnoea Depression Atelectasis Hypoventilation Pulmonary embolism Pulmonary oedema Respiratory distress Respiratory failure Wheezing Gastrointestinal disorders Nausea Constipation Diarrhoea Vomiting Dyspepsia Flatulence Eructation Dry Mouth Retching Abdominal discomfort Abdominal distension Abdominal Pain upper Epigastric discomfort Gastritis Gastroesophageal reflux disease Hypoaesthesia oral
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-04T09:41:00Z · SHA-256 11a627f517ef165f1c214a9467017376a3e2707d6037112cbc10731d39d973c1 · Passage 1f263c0afd7d0f2278637b186b72471006b062b1e150a25dae4ad8f597a7a739 · Zeichen 2439–6530 im Abschnitt